Paediatric research studies

Change my appointment
x

Appointment Form

If you have been given an outpatient appointment at the hospitals and are unable to attend for whatever reason you can use the form below.

It is really important that you let us know of any changes as soon as possible. This means we can offer the original appointment to another patient.

Please complete the form below with your contact details and as much information as possible. You can find most of the information we need on your appointment letter.

If you have any problems using this form, please call the number on your appointment letter and we will do our best to help you. You will receive a response from us so you know it has been received and actioned.

If you wish to change the date and time of your appointment you, you can click the re-book option and state any dates that are not suitable for you, or you can contact us using the number on your appointment letter.

x

Contact Form


Make an enquiry

ADDRESS2

An incident and high risk type 1 diabetes cohort - After Diagnosis Diabetes Research Support System-2 (ADDRESS-2)

The purpose of the study is to identify children and adults newly diagnosed with type 1 diabetes and their brothers and sisters (siblings), who might be interested in taking part in future diabetes research studies. We want to collect information and blood samples from these people to understand more about the development and progression of type 1 diabetes, and to help find suitable trials of new treatments or other studies into diabetes that they might want to take part in. When we find suitable trials or diabetes studies we will write to the eligible people to ask if they would be interested in taking part.

PREDNOS2

Short course daily prednisolone therapy at the time of upper respiratory tract infection in children with relapsing steroid sensitive nephrotic syndrome; the PREDNOS 2 study.

Children with nephrotic syndrome suffer from disease relapses, where the protein in the urine returns. When these occur, treatment with high dose prednisolone is commenced and this may be associated with a number of side-effects, such as a puffy face, high blood pressure or changes in mood. For this reason, every effort is made to prevent relapses from happening. This generally involves the use of either low dose every other day prednisolone, or other drugs such as levamisole, ciclosporin or mycophenolate mofetil.

It is well know that relapses may be caused by upper respiratory tract infection (URTI– the common cold). The purpose of this study is to see whether giving a six day course of daily prednisolone when children develop an URTI prevents relapses from developing: we will study this in a large population of UK children with relapsing nephrotic syndrome.